Page last updated: 2024-10-16

beta-alanine and Arterial Occlusive Diseases

beta-alanine has been researched along with Arterial Occlusive Diseases in 4 studies

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"This article reports an acute ischemic stroke after cardioversion and atrial flutter catheter ablation in a patient on treatment by dabigatran 110mg twice daily."7.79[Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran]. ( Amara, W; Guedeney, P; Iusuf, A, 2013)
"This article reports an acute ischemic stroke after cardioversion and atrial flutter catheter ablation in a patient on treatment by dabigatran 110mg twice daily."3.79[Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran]. ( Amara, W; Guedeney, P; Iusuf, A, 2013)
"Dabigatran is a reversible, direct thrombin inhibitor, which is administered as dabigatran etexilate, the oral prodrug."2.48New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. ( Dahl, OE, 2012)
"Dabigatran was stopped and dalteparin 5000 International Units/bid and 40 μg alprostadil infusions were started."1.38Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy. ( Finsterer, J; Reiter, M; Schäffl-Doweik, L; Stöllberger, C, 2012)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amara, W1
Guedeney, P1
Iusuf, A1
Sheffield, WP1
Lambourne, MD1
Eltringham-Smith, LJ1
Bhakta, V1
Arnold, DM1
Crowther, MA1
Dahl, OE1
Stöllberger, C1
Reiter, M1
Schäffl-Doweik, L1
Finsterer, J1

Reviews

1 review available for beta-alanine and Arterial Occlusive Diseases

ArticleYear
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
    Vascular health and risk management, 2012, Volume: 8

    Topics: Administration, Oral; Animals; Antithrombins; Arterial Occlusive Diseases; Benzimidazoles; beta-Alan

2012

Other Studies

3 other studies available for beta-alanine and Arterial Occlusive Diseases

ArticleYear
[Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran].
    Annales de cardiologie et d'angeiologie, 2013, Volume: 62, Issue:5

    Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Atrial Flutter; Benzimidazoles; beta-Alanine; Cat

2013
γT -S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo.
    Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:7

    Topics: Animals; Anticoagulants; Arterial Occlusive Diseases; Benzimidazoles; beta-Alanine; Bleeding Time; B

2014
Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy.
    Vascular and endovascular surgery, 2012, Volume: 46, Issue:4

    Topics: Aged; Anticoagulants; Antithrombins; Arterial Occlusive Diseases; Atrial Fibrillation; Benzimidazole

2012